Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.
Top Providers in Texas
| Provider | Medicare | Services |
|---|---|---|
| Flores, John MD | $1.17 | 86.9K |
| Winful, Candice M.D. | $1.13 | 45.1K |
| Shalev, Daniel M.D. | $1.05 | 23.4K |
| Pate, John MD | $0.91 | 14.4K |
| Rush, John MD | $1.09 | 10.7K |
| Vredenburgh, Jesse D.O. | $0.98 | 3.0K |
| Smith, Darwin MD | $0.84 | 2.9K |
| Hooda, Zehra D.O. | $0.81 | 2.3K |
| Daha, Ali M.D. | $1.14 | 740 |
| Btdi Jv Llp | $1.01 | 551 |
| Sharma, Rajesh MD | $1.08 | 491 |
| Jones, Jeremy M.D. | $0.87 | 480 |
| Btdi Jv Llp | $1.03 | 346 |
| Btdi Jv, Llp | $1.07 | 219 |
| Btdi Jv, Llp | $1.02 | 154 |
| Ellent, David M.D. | $1.04 | 101 |
| Btdi Jv Llp | $0.96 | 37 |
Texas Pricing in Context
In Texas, CPT code Q9965 (Low Osmolar Contrast Material, 100-199 Mg/ml Iodine Concentration, Per Ml) carries an average Medicare payment of $1.11 — 14% above the national benchmark of $0.97. 83 providers across the state submitted claims for this procedure in 2023, performing 194.0K total services. Individual payments in TX ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.
The average billed charge in Texas is $2.21, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Texas sits above the national Medicare average, commercial rates in the state may also run higher than the US median.
Using RAND 2024 commercial-to-Medicare ratios for Temporary Codes procedures, the estimated commercial insurance price in Texas lands near $3.20, with self-pay cash prices typically around $1.65. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.
Frequently Asked Questions
How much does Low Osmolar Contrast Material, 100-199 Mg/ml Iodine Concentration, Per Ml cost in Texas?
The average Medicare payment for Low Osmolar Contrast Material, 100-199 Mg/ml Iodine Concentration, Per Ml in Texas is $1.11, which is 14% above the national average of $0.97. Providers in TX typically bill $2.21 for this procedure.
What does Low Osmolar Contrast Material, 100-199 Mg/ml Iodine Concentration, Per Ml cost with insurance in Texas?
With commercial insurance in Texas, Low Osmolar Contrast Material, 100-199 Mg/ml Iodine Concentration, Per Ml costs an estimated $3.20. Without insurance, the estimated cash price is $1.65. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.
How many providers perform Low Osmolar Contrast Material, 100-199 Mg/ml Iodine Concentration, Per Ml in Texas?
83 providers in Texas billed Medicare for Low Osmolar Contrast Material, 100-199 Mg/ml Iodine Concentration, Per Ml in 2023, performing 194.0K total services. Medicare payments ranged from N/A to N/A depending on the provider.
Is Low Osmolar Contrast Material, 100-199 Mg/ml Iodine Concentration, Per Ml cheaper in Texas than the national average?
No — Low Osmolar Contrast Material, 100-199 Mg/ml Iodine Concentration, Per Ml costs 14% above the national average in Texas. The state average Medicare payment is $1.11 compared to $0.97 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.
Related Guides
Related Data Sources
Data from CMS Medicare Physician & Other Practitioners (2023).
Read our methodology — how this data is sourced, computed, and verified.